Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Hematology and Blood Transfusion
Published in: Indian Journal of Hematology and Blood Transfusion 1/2021

01-01-2021 | Heart Surgery | Short Communication

The Impact of Thromboelastography on Blood Transfusion Policy in Adult Cardiac Surgery—A Retrospective Observational Study from Eastern India

Authors: Suvro Sankha Datta, Dibyendu De

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2021

Login to get access

Abstract

This study was conducted to determine the impact of thromboelastography (TEG) on blood transfusion policy regarding utilization and preparation of cryoprecipitate in adult cardiac surgery. The differences in total transfusion requirement, length of postoperative ICU stay and 24 h mortality were also studied after introduction of TEG in transfusion protocol. It was a retrospective, single-center, observational study conducted in adult patients underwent cardiac surgery from April 2008 to March 2016. Two thousand patients underwent surgery when TEG was used compared with 1000 control patients before availability of TEG. Significantly more patients in the TEG group versus the control group received cryoprecipitate (41 vs. 7%; p < 0.05), while fewer received a transfusion (60 vs. 87.5%; p < 0.05). Significant increase in cryoprecipitate preparation was observed after introduction of TEG. Patients underwent surgery in TEG group showed substantial reduction in administration of PRBC (2.1 vs. 3.5 U; p < 0.05); FFP (2.4 vs. 3.8 U; p < 0.05) and platelets (1.1 vs. 2.7 U; p < 0.05) compared to control group without compromising the length of ICU stay or postoperative mortality. A TEG-guided approach in adult patients undergoing cardiac surgery may increase the use of cryoprecipitate, while decreasing the overall requirement of blood transfusion.
Literature
1.
Makar M, Taylor J, Zhao M, Farrohi A, Trimming M, D’Attellis N (2010) Perioperative coagulopathy, bleeding, and hemostasis during cardiac surgery: a comprehensive review. ICU Dir 1:17–27CrossRef
2.
Görlinger K, Shore-Lesserson L, Dirkmann D, Hanke AA, Rahe- Meyer N, Tanaka KA (2013) Management of hemorrhage in cardiothoracic surgery. J Cardiothorac Vasc Anesth 27:S20–S34CrossRef
3.
Ferraris VA, Saha SP, Oestreich JH, Song HK, Rosengart T, Reece TB et al (2012) Update to the society of thoracic surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 94:1761–1781CrossRef
4.
Carroll RC, Chavez JJ, Snider CC, Meyer DS, Muenchen RA (2006) Correlation of perioperative platelet function and coagulation tests with bleeding after cardiopulmonary bypass surgery. J Lab Clin Med 147:197–204CrossRef
5.
Crowther MA, Warkentin TE (2008) Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood 111:4871–4879CrossRef
6.
Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Flinck A, Skrtic S et al (2009) Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 102:137–144CrossRef
7.
Sniecinski RM, Chen EP, Makadia SS, Kikura M, Bolliger D, Tanaka KA (2010) Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest. J Cardiothorac Vasc Anesth 24:959–963CrossRef
8.
Fassl J, Matt P, Eckstein F, Filipovic M, Gregor M, Zenklusen U et al (2013) Transfusion of allogeneic blood products in proximal aortic surgery with hyopthermic circulatory arrest: effects of thromboelastometry-guided transfusion management. J Cardiothorac Vasc Anesth 27(6):1181–1188CrossRef
9.
Kawashima S, Suzuki Y, Sato T, Kikura M, Katoh T, Sato S (2016) Four-group classification based on fibrinogen level and fibrin polymerization associated with postoperative bleeding in cardiac surgery. Clin Appl Thromb Hemost 22:648–655CrossRef
10.
Nuttall GA, Oliver WC, Ereth MH, Santrach PJ (1997) Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 11(7):815–823CrossRef
11.
Segal JB, Dzik WH, Transfusion Medicine/Hemostasis Clinical Trials Network (2005) Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 45(9):1413–1425CrossRef
12.
Vasques F, Spiezia L, Manfrini A et al (2017) Thromboelastometry guided fibrinogen replacement therapy in cardiac surgery: a retrospective observational study. J Anesth 31(2):286–290CrossRef
13.
Hanna JM, Keenan JE, Wang H, Andersen ND, Gaca JG, Lombard FW, Welsby IJ, Hughes GC (2016) Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg 151:376–382CrossRef
14.
Ternström L, Radulovic V, Karlsson M, Baghaei F, Hyllner M, Bylock A, Hansson KM, Jeppsson A (2010) Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study. Thromb Res 126:e128–e133CrossRef
15.
Ranucci M, Baryshnikova E (2016) Fibrinogen supplementation after cardiac surgery: insights from the zero-plasma trial (ZEPLAST). Br J Anaesth 116:618–623CrossRef
16.
Perez-Ferrer A, Vicente-Sanchez J, Carceles-Baron MD, Van der Linden P, Faraoni D (2015) Early thromboelastometry variables predict maximum clot firmness in children undergoing cardiac and noncardiac surgery. Br J Anaesth 115:896–902CrossRef
17.
Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M (2013) Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. J Thorac Cardiovasc Surg 145:S178–S185CrossRef
18.
Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M (2013) Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 118:40–50CrossRef
19.
Ichikawa J, Marubuchi T, Nishiyama K, Kodaka M, Görlinger K, Ozaki M et al (2018) Introduction of thromboelastometry guidance for the administration of fresh frozen plasma is associated with decreased allogeneic blood transfusions and postoperative blood loss in cardiopulmonary bypass surgery. Blood Transfus 16(3):244–252PubMedPubMedCentral
20.
Fleming K, Redfern RE, March RL et al (2017) TEG-directed transfusion in complex cardiac surgery: impact on blood product usage. J Extra Corpor Technol 49:283–290PubMedPubMedCentral
Metadata
Title
The Impact of Thromboelastography on Blood Transfusion Policy in Adult Cardiac Surgery—A Retrospective Observational Study from Eastern India
Authors
Suvro Sankha Datta
Dibyendu De
Publication date
01-01-2021
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2021
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01310-y

Other articles of this Issue 1/2021

Indian Journal of Hematology and Blood Transfusion 1/2021 Go to the issue

Correspondence

Successful Treatment of Acquired Hemophilia A with Bortezomib Plus Low Dose Rituximab in a Patient with Renal Failure and Severe Pneumonia

Original Article

Plateletpheresis in the Era of Automation: Optimizing Donor Safety and Product Quality Using Modern Apheresis Instruments

Review Article

Recent Advances in Molecular Diagnosis and Prognosis of Childhood B Cell Lineage Acute Lymphoblastic Leukemia (B-ALL)

Correspondence

Primary Mediastinal B Cell Lymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol

Short Communication

Non Malignant Lymphoproliferative Disorders in Children: A Case Series

Images

Loss of Normal Polyploid Spectrum as Marker of Clonality in Acute Megakaryoblastic Leukemia Evolving from Pre-Existing Primary Myelofibrosis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits